401 Epizód

  1. Episode 163: The Uromigos Debate - Treatment of favorable risk renal cancer

    Közzétéve: 2022. 03. 21.

  2. Episode 162: Debate - Adjuvant nivolumab for bladder cancer

    Közzétéve: 2022. 03. 14.

  3. Episode 161: Platinum eligibility in urothelial cancer

    Közzétéve: 2022. 03. 07.

  4. Episode 160: APCCC - PMSA PET as a diagnostic

    Közzétéve: 2022. 02. 28.

  5. Episode 159: ASCO GU 2022 Adjuvant and neoadjuvant therapy in renal cancer

    Közzétéve: 2022. 02. 19.

  6. Episode 158: ASCO GU 2022 PROpel Phase III olaparib and abiraterone in renal cancer

    Közzétéve: 2022. 02. 19.

  7. Episode 156: ASCO GU 2022 1st line olaparib and durvalumab in bladder cancer

    Közzétéve: 2022. 02. 18.

  8. Episode 157: ASCO GU 2022 Sasatuzimab and pembrolizumab in bladder cancer

    Közzétéve: 2022. 02. 18.

  9. Episode 154: ASCO GU 2022 MAGNITUDE trial of niraparib and abiraterone in metastatic CRPC

    Közzétéve: 2022. 02. 17.

  10. Episode 155: ASCO GU 2022 ARASENS trial of darolutamide plus chemo vs chemo alone in hormone sensitive advanced prostate cancer

    Közzétéve: 2022. 02. 17.

  11. Episode 153: Overview of PARP inhibition in prostate cancer

    Közzétéve: 2022. 02. 10.

  12. Episode 152: The Uromigos Paper of the Month - Zr-Pembrolizumab PET Imaging

    Közzétéve: 2022. 02. 07.

  13. Episode 151: Bladder Cancer ESMO Guidelines update

    Közzétéve: 2022. 01. 31.

  14. Episode 150: Comparing the quality of life data in renal trials

    Közzétéve: 2022. 01. 24.

  15. Episode 149: Treatment-free survival for ipilimumab and nivolumab

    Közzétéve: 2021. 12. 28.

  16. Episode 148: The Uromigos Paper of the Month - Stereotactic radiotherapy for advanced renal cancer

    Közzétéve: 2021. 12. 21.

  17. Episode 147: Renal Cancer Christmas Special

    Közzétéve: 2021. 12. 17.

  18. Episode 146: Bladder Cancer Christmas Special

    Közzétéve: 2021. 12. 13.

  19. Episode 145: Prostate Cancer Christmas Special

    Közzétéve: 2021. 12. 06.

  20. Episode 144: Pembrolizumab for bladder cancer

    Közzétéve: 2021. 12. 02.

13 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site